Selecting Patients With Atrial Fibrillation for Anticoagulation
Background— The rate of stroke in atrial fibrillation (AF) depends on the presence of comorbid conditions and the use of antithrombotic therapy. Although adjusted-dose warfarin ...
Publications
5 shownFactors Associated With Ischemic Stroke During Aspirin Therapy in Atrial Fibrillation
Background and Purpose —Nonvalvular atrial fibrillation (AF) is a strong, independent risk factor for stroke, but the absolute rate of stroke varies widely among AF patients, im...
Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation
Adjusted-dose warfarin and antiplatelet agents reduce stroke by approximately 60% and by approximately 20%, respectively, in patients who have atrial fibrillation. Warfarin is s...
Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation
Adjusted-dose warfarin and aspirin reduce stroke in patients with atrial fibrillation, and warfarin is substantially more efficacious than aspirin. The benefit of antithrombotic...
Frequent Co-Authors
Researcher Info
- h-index
- 5
- Publications
- 5
- Citations
- 8,380
- Institution
- Mayo Clinic in Arizona
External Links
Identifiers
- ORCID
- 0000-0002-0838-1739
Impact Metrics
h-index
5
h-index: Number of publications with at least h citations each.